UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
901
Axalta
AXTA
$7.1B
| $28.8M | 0.01% |
969,195
+276,723
| +40% | +$8.62M |
2015 Q2
40 quarters
|
|
902
Chewy
CHWY
$8.37B
| $28.7M | 0.01% |
672,384
+288,418
| +75% | +$11.5M |
2020 Q2
20 quarters
|
|
903
Starwood Property Trust
STWD
$4.58B
| $28.6M | 0.01% |
1,424,818
+1,017,569
| +250% | +$19.8M |
2013 Q2
48 quarters
|
|
904
COPT Defense Properties
CDP
$3.77B
| $28.6M | 0.01% |
1,035,757
+201,715
| +24% | +$5.46M |
2013 Q2
48 quarters
|
|
905
Globus Medical
GMED
$10.2B
| $28.4M | 0.01% |
481,072
+133,545
| +38% | +$8.63M |
2013 Q2
48 quarters
|
|
906
Merit Medical Systems
MMSI
$5.2B
| $28.3M | 0.01% |
302,951
+16,008
| +6% | +$1.52M |
2023 Q1
9 quarters
|
|
907
Watts Water Technologies
WTS
$11.8B
| $28.2M | 0.01% |
114,730
+15,852
| +16% | +$3.57M |
2013 Q2
48 quarters
|
|
908
Vail Resorts
MTN
$5.33B
| $28.2M | 0.01% |
179,517
+31,282
| +21% | +$4.65M |
2013 Q2
48 quarters
|
|
909
DELISTED
Qorvo
QRVO
| $28.2M | 0.01% |
331,874
-26,848
| -7% | -$1.94M |
2015 Q1
41 quarters
|
|
910
AutoNation
AN
$5.06B
| $28M | 0.01% |
140,907
+42,297
| +43% | +$7.64M |
2013 Q2
48 quarters
|
|
911
Lincoln National
LNC
$7.7B
| $28M | 0.01% |
808,632
+185,310
| +30% | +$6.06M |
2013 Q2
48 quarters
|
|
912
Range Resources
RRC
$9.78B
| $27.8M | 0.01% |
683,127
+216,331
| +46% | +$8.15M |
2013 Q2
48 quarters
|
|
913
Whirlpool
WHR
$1.8B
| $27.7M | 0.01% |
273,144
+58,226
| +27% | +$4.84M |
2013 Q2
48 quarters
|
|
914
DELISTED
Blueprint Medicines
BPMC
| $27.7M | 0.01% |
215,946
-28,465
| -12% | -$2.96M |
2017 Q1
33 quarters
|
|
915
Albemarle
ALB
$11.6B
| $27.6M | 0.01% |
440,007
-194,891
| -31% | -$11.5M |
2013 Q2
48 quarters
|
|
916
Nexstar Media Group
NXST
$4.94B
| $27.6M | 0.01% |
159,403
+26,594
| +20% | +$4.36M |
2013 Q2
48 quarters
|
|
917
WEX
WEX
$5.95B
| $27.5M | 0.01% |
187,425
-2,746
| -1% | -$369K |
2013 Q2
48 quarters
|
|
918
FTI Consulting
FCN
$3.87B
| $27.5M | 0.01% |
170,231
+38,515
| +29% | +$6.29M |
2013 Q2
48 quarters
|
|
919
Crocs
CROX
$5.64B
| $27.5M | 0.01% |
271,226
+59,921
| +28% | +$6.11M |
2013 Q2
48 quarters
|
|
920
Sonoco
SON
$4.86B
| $27.5M | 0.01% |
630,218
+85,039
| +16% | +$3.8M |
2013 Q2
48 quarters
|
|
921
Darling Ingredients
DAR
$9.84B
| $27.4M | 0.01% |
723,103
+122,326
| +20% | +$4.03M |
2014 Q2
44 quarters
|
|
922
Unity
U
$18.2B
| $27.4M | 0.01% |
1,131,542
+318,366
| +39% | +$7M |
2020 Q4
18 quarters
|
|
923
BioNTech
BNTX
$22.3B
| $27.3M | 0.01% |
256,874
+38,452
| +18% | +$3.88M |
2020 Q2
20 quarters
|
|
924
Vontier
VNT
$4.38B
| $27.1M | 0.01% |
735,507
+151,942
| +26% | +$5.17M |
2021 Q1
17 quarters
|
|
925
Brookfield Asset Management
BAM
$71.3B
| $27.1M | 0.01% |
490,554
+229,504
| +88% | +$12.3M |
2024 Q2
4 quarters
|
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.